- abnormal response/metabolism to endogenous compounds / MGI
- decreased circulating interleukin-6 level / MGI
- decreased sensitivity to induced morbidity/mortality / MGI
- decreased physiological sensitivity to xenobiotic / MGI
- decreased sensitivity to xenobiotic induced morbidity/mortality / MGI
- abnormal sleep pattern / MGI
- impaired central nervous system regeneration / MGI
- increased sensitivity to induced cell death / MGI
- increased susceptibility to bacterial infection induced morbidity/mortality / MGI
- impaired humoral immune response / MGI
- decreased susceptibility to bacterial infection / MGI
- decreased circulating alanine transaminase level / MGI
- abnormal Peyer's patch morphology / MGI
- abnormal immune system physiology / MGI
- abnormal lymph node B cell domain morphology / MGI
- abnormal Peyer's patch follicle morphology / MGI
- increased susceptibility to bacterial infection / MGI
- decreased susceptibility to experimental autoimmune encephalomyelitis / MGI
- increased susceptibility to parasitic infection / MGI
- increased susceptibility to type I hypersensitivity reaction / MGI
- decreased Peyer's patch number / MGI
- absent follicular dendritic cells / MGI
- decreased IgG1 level / MGI
- decreased interleukin-6 secretion / MGI
- decreased T cell proliferation / MGI
- decreased interferon-gamma secretion / MGI
- decreased interleukin-2 secretion / MGI
- increased susceptibility to experimental autoimmune encephalomyelitis / MGI
- decreased susceptibility to autoimmune diabetes / MGI
- periinsulitis / MGI
B6.129-Tnfrsf1btm1Mwm Tnfrsf1atm1Blt/Cnrm
Status | Available to order |
EMMA ID | EM:02532 |
International strain name | B6.129-Tnfrsf1btm1Mwm Tnfrsf1atm1Blt/Cnrm |
Alternative name | B6.129S-Tnfrsf1a |
Strain type | Targeted Mutant Strains : Knock-out |
Allele/Transgene symbol | Tnfrsf1atm1Blt, |
Gene/Transgene symbol | Tnfrsf1a |
Information from provider
Provider | Horst Bluethmann |
Provider affiliation | Pharmaceuticals Divisons, F. Hoffmann-La Roche Ltd. |
Genetic information | The double mutant mice lacking both Tnfrsf1a and Tnfrsf1b were generated by intercrossing the singly deficient mice. B6.129S-Tnfrsf1atm1Blt: A genomic fragment containing the exons II and III and 5' sequences from exon IV of the Tnfrsf1a gene was replaced by a neomycin resistance gene flanked by phosphoglycerate kinase-1 (pgk-1) promoter- and poly (A)+ signal sequences. The insertion of the neo cassette resulted in the introduction of new BglII and StuI sites which were used to confirm the targeting event. The Tnfrsf1a homologies provided at both sides of the neo cassette were 868 bp and ~ 5 kb, respectively. The targeting vector was linearized with XbaI before electroporation into E14 embryonic stem cells derived from 129/Sv mice. B6.129S-Tnfrsf1btm1Mwm: A neomycin resistance gene under the control phosphoglycerate kinase-1 (pgk-1) promoter was inserted into the BstBII site in the second exon, which contains the signal peptide region of TNFR2. |
Phenotypic information | B6.129S-Tnfrsf1atm1Blt: Mice lacking the tumor necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes (PMID: 8395024) B6.129S-Tnfrsf1btm1Mwm: Mice deficient for Tnfrsf1b show decreased T cell proliferation, decreased interferon-gamma secretion, and decreased interleukin-2 secretion (PMID: 7990930). |
Breeding history | The single deficient strains were backcrossed each to C57BL/6 for 6 generations, then intercrossed. |
References |
|
Homozygous fertile | yes |
Homozygous viable | yes |
Homozygous matings required | yes |
Immunocompromised | yes |
Information from EMMA
Archiving centre | CNR, Consiglio Nazionale delle Ricerche, Monterotondo, Italy |
Disease and phenotype information
Orphanet associated rare diseases, based on orthologous gene matching
- Tumor necrosis factor receptor 1 associated periodic syndrome / Orphanet_32960
- Sézary syndrome / Orphanet_3162
- Classic mycosis fungoides / Orphanet_2584
MGI phenotypes (allele matching)
Literature references
- Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes.;Rothe J, Lesslauer W, Lötscher H, Lang Y, Koebel P, Köntgen F, Althage A, Zinkernagel R, Steinmetz M, Bluethmann H, ;1993;Nature;364;798-802; 8395024
- Decreased sensitivity to tumour-necrosis factor but normal T-cell development in TNF receptor-2-deficient mice.;Erickson S L, de Sauvage F J, Kikly K, Carver-Moore K, Pitts-Meek S, Gillett N, Sheehan K C, Schreiber R D, Goeddel D V, Moore M W, ;1994;Nature;372;560-3; 7990930
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).